Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01671696 · ClinicalTrials.gov registry record
Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy
A clinical trial, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- 80
- Enrollment target
NCT01671696 is a clinical trial that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 80 participants.
The verdict
NCT01671696 has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The main hypothesis being tested is that magnetic resonance imaging and serologic biomarkers of apoptosis and extracellular matrix remodeling will precede echocardiographic indices of systolic and diastolic function among childhood cancer survivors treated with anthracyclines thus allowing evaluation of new therapies to prevent and manage heart failure in these patients.
Interventions
- OTHER Cardiac MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2011-11-15 |
| Est. Completion | 2017-10-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01671696
The ClinicalTrials.gov registry entry for NCT01671696 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac MRI is the first listed.
NCT01671696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01671696 about?
NCT01671696 is a clinical study titled "Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy". The main hypothesis being tested is that magnetic resonance imaging and serologic biomarkers of apoptosis and extracellular matrix remodeling will precede echocardiographic indices of systolic and diastolic function among childhood cancer survivors treated with anthracyclines thus allowing evaluatio...
What is the current status of trial NCT01671696?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2011-11-15. Estimated completion is 2017-10-06.
What interventions are being tested in trial NCT01671696?
The interventions under investigation include: Cardiac MRI (OTHER).
Who is sponsoring clinical trial NCT01671696?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.